Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on March 8, 2004

Circulation. 2004
Published online before print March 8, 2004, doi: 10.1161/01.CIR.0000118469.77718.3E
A more recent version of this article appeared on March 16, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
109/10/1278    most recent
01.CIR.0000118469.77718.3Ev1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miner, S. E.S.
Right arrow Articles by Parker, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miner, S. E.S.
Right arrow Articles by Parker, J. D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-ARGININE
Related Collections
Right arrow Pathophysiology
Right arrow Chronic ischemic heart disease
Right arrow Endothelium/vascular type/nitric oxide

Submitted on January 22, 2003
Revised on November 24, 2003
Accepted on December 1, 2003

L-Arginine Transport in the Human Coronary and Peripheral Circulation

S. E.S. Miner MD, A. Al-Hesayen MD, S. Kelly RN, T. Benson RN, J. J. Thiessen PhD, V. R. Young PhD, and J. D. Parker MD*

From the Departments of Medicine and Pharmacy (J.J.T.), Mount Sinai Hospital and University Health Network, University of Toronto, Ontario, Canada, and the Department of Laboratory and Human Nutrition and Clinical Research Center, Massachusetts Institute of Technology, Cambridge (V.R.Y.).

* To whom correspondence should be addressed. E-mail: jdp{at}ca.inter.net.

Background--Nitric oxide synthase (NOS) uses arginine for the production of nitric oxide (NO). High intracellular concentrations of arginine suggest that NOS activity should be independent of plasma arginine supply. However, under certain conditions, increased plasma arginine concentrations appear to be associated with increased NOS activity. The purpose of this study was to explore arginine transport within the human coronary and peripheral circulation

Methods and Results--Mass-labeled 15N2-arginine was infused to steady state before cardiac catheterization in 31 patients. After diagnostic angiography, a catheter was placed in the coronary sinus. The transcardiac concentration gradient (aorta-coronary sinus) of 15N2-arginine was used as a measure of arginine transport at baseline and during infusions of acetylcholine and NG-monomethyl-L-arginine (L-NMMA). No gradient was detected at rest. During the infusion of acetylcholine, a significant gradient was detected (2.5±1.2 µmol/L, P=0.01) corresponding to a fractional extraction of 11.7±7.5%. This is consistent with in vitro studies that suggest that stimulation of NOS induces arginine transport. During the infusion of L-NMMA, the concentration of 15N2-arginine increased in the coronary sinus, producing a gradient of -3.9±1.3 µmol/L (P=0.0002), corresponding to a fractional production of 20.5±5.0%. This is consistent with in vitro studies that suggest that L-NMMA induces the efflux of arginine from the cell to the extracellular space via transporter-mediated transstimulation.

Conclusions--The use of steady-state 15N2-arginine to examine transorgan L-arginine gradients represents a novel tool for the study of L-arginine transport and the mechanisms of endothelial and NOS dysfunction.


Key words: nitric oxide synthase • coronary disease • endothelium




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
A. Imamura, R. Takahashi, R. Murakami, H. Kataoka, X. W. Cheng, Y. Numaguchi, T. Murohara, and K. Okumura
The effects of endothelial nitric oxide synthase gene polymorphisms on endothelial function and metabolic risk factors in healthy subjects: the significance of plasma adiponectin levels
Eur. J. Endocrinol., February 1, 2008; 158(2): 189 - 195.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Tentolouris, D. Tousoulis, and C. Stefanadis
L-Arginine "Paradox" in Coronary Atherosclerosis
Circulation, August 17, 2004; 110(7): e71 - e71.
[Full Text] [PDF]